SCHEMBL22736004

SCHEMBL22736004

CS(=O)(=O)CCC(C#N)C1=C/CCC/C=C(n2cc(-c3ccnc(N)c3N)cn2)/C=C\1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22736320 0.77 GRM4 (0.32) —
SCHEMBL29567465 0.77 GRM4 (0.32) —
SCHEMBL22735943 0.75 — —
SCHEMBL29480651 0.68 — —
SCHEMBL29567639 0.65 GRM4 (0.32) —
SCHEMBL22736041 0.65 GRM4 (0.32) —
SCHEMBL22735964 0.65 GRM4 (0.32) —
SCHEMBL22736335 0.65 JAK2 (0.31) —
SCHEMBL29480764 0.65 GRM4 (0.32) —
SCHEMBL22736542 0.64 GRM4 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020240586-A1 NOVEL COMPOUNDS FOR INHIBITION OF JANUS KINASE 1 MANKIND PHARMA LTD. (IN) 2020-12-03 — — WO disclosed
Send feedback